WallStreetZenWallStreetZen

NASDAQ: SMLR
Semler Scientific Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

SMLR past earnings growth

How has SMLR's earnings growth performed historically?
Company
35.02%
Industry
531.37%
Market
117.76%
SMLR's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SMLR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SMLR's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SMLR past revenue growth

How has SMLR's revenue growth performed historically?
Company
8.22%
Industry
10.7%
Market
15.15%
SMLR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SMLR's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SMLR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SMLR earnings and revenue history

Current Revenue
$65.9M
Current Earnings
$21.7M
Current Profit Margin
32.9%

SMLR Return on Equity

Current Company
30.4%
Current Industry
7.3%
Current Market
28.2%
SMLR's Return on Equity (30.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SMLR announces earnings.

SMLR Return on Assets

Current Company
27.4%
Current Industry
5.9%
SMLR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SMLR Return on Capital Employed

Current Company
32.41%
Current Industry
9%
SMLR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SMLR vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SMLR$65.88M$25.91M$21.69M+22.60%+26.45%
ARAY$430.55M-$12.16M-$21.49M+0.73%N/A
CLPT$26.16M-$19.24M-$20.63M+26.11%N/A
TELA$63.15M-$34.16M-$40.30M+41.24%N/A
CVRX$42.09M-$48.82M-$52.01M+169.26%N/A
View Top Medical Device Stocks

Semler Scientific Earnings & Revenue FAQ

What were SMLR's earnings last quarter?

On Invalid Date, Semler Scientific (NASDAQ: SMLR) reported Q1 2024 earnings per share (EPS) of $0.88, up 18.92% year over year. Total Semler Scientific earnings for the quarter were $6.07 million. In the same quarter last year, Semler Scientific's earnings per share (EPS) was $0.74.

If you're new to stock investing, here's how to buy Semler Scientific stock.

What was SMLR's earnings growth in the past year?

As of Q2 2024, Semler Scientific's earnings has grown 35.02% year over year. This is 496.35 percentage points lower than the US Medical Devices industry earnings growth rate of 531.37%. Semler Scientific's earnings in the past year totalled $21.69 million.

What was SMLR's revenue last quarter?

On Invalid Date, Semler Scientific (NASDAQ: SMLR) reported Q1 2024 revenue of $15.90 million up 12.65% year over year. In the same quarter last year, Semler Scientific's revenue was $18.21 million.

What was SMLR's revenue growth in the past year?

As of Q2 2024, Semler Scientific's revenue has grown 8.22% year over year. This is 2.48 percentage points lower than the US Medical Devices industry revenue growth rate of 10.7%. Semler Scientific's revenue in the past year totalled $65.88 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.